Last updated: 2026-09-09 19:18:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Kezar Life Sciences, Inc. (KZR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Kezar Life Sciences, Inc. (KZR) is currently trading at $-- as of --, -- from the previous close of $--
During today's regular trading session, KZR has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.
Over the past seven days, Kezar Life Sciences, Inc. (KZR) moved from $7.29 to $7.29, representing no net price change.
The stock traded between $7.23 and $7.47 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 170.64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Kezar Life Sciences, Inc. (KZR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.